In a filing, Cardinal Health, Inc. revealed its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Cardinal Health, Inc. revealed its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Cardinal Health, Inc.’s recently made public that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Cardinal Health, Inc.’s recently made public that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cardinal Health,